Sélectionnez l'édition
Pays
Objectif principal
Maladie
Type d'Organisation
Partie prenante
Qualité
États-Unis (2)
Organization / System Development
Musculoskeletal/Multiple Sclerosis (MS) (1)
Patient Advocacy Organization (4)
Pharmaceutical companies or industry (incl. Medical device and biotech companies)
Continuity and sustainability
Clinical study phase II